Vertex Pharmaceuticals (VRTX) Times Interest Earned (2009 - 2026)
Vertex Pharmaceuticals' (VRTX) quarterly Times Interest Earned came in at $2.71 in Q1 2026, up 53.59% year-on-year from $1.76 in Q1 2025, and down 99.12% quarter-over-quarter from $309.21 in Q4 2025.
Vertex Pharmaceuticals (VRTX) Times Interest Earned (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals' Times Interest Earned history runs 18 years deep, the most recent figure standing at $2.71 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 53.59% year-over-year to $2.71 in Q1 2026; TTM through Mar 2026 was $11.14, a 636.27% increase from a year earlier, with the FY2025 full-year figure at $9.56, up 1501.17% from the prior year.
- Times Interest Earned retreated to $2.71 in Q1 2026 per VRTX's latest filing, from $309.21 in the prior quarter.
- Across five years, Times Interest Earned topped out at $309.21 in Q4 2025 and bottomed at -$11.36 in Q2 2024.
- The 5-year median for Times Interest Earned is $4.1 (2023), against an average of $32.02.
- Across the five-year window, Times Interest Earned slumped 377.22% in 2024 and surged 2482.74% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at $92.28 in 2022, then gained by 1.06% to $93.25 in 2023, then sank by 87.16% to $11.97 in 2024, then jumped by 2482.74% to $309.21 in 2025, then slumped by 99.12% to $2.71 in 2026.
- Per Business Quant, the three latest VRTX Times Interest Earned figures stand at $2.71 (Q1 2026), $309.21 (Q4 2025), and $2.81 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 3.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.71 |
| Dec 31, 2025 | 309.21 |
| Sep 30, 2025 | 2.81 |
| Jun 30, 2025 | 2.79 |
| Mar 31, 2025 | 1.76 |
| Dec 31, 2024 | 11.97 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | -11.36 |
| Mar 31, 2024 | 3.78 |
| Dec 31, 2023 | 93.25 |
| Sep 30, 2023 | 4.23 |
| Jun 30, 2023 | 4.10 |
| Mar 31, 2023 | 3.35 |
| Dec 31, 2022 | 92.28 |
| Sep 30, 2022 | 7.78 |
| Jun 30, 2022 | 7.62 |
| Mar 31, 2022 | 7.58 |
| Dec 31, 2021 | -68.57 |
| Sep 30, 2021 | 11.85 |
| Jun 30, 2021 | -0.45 |